Hyperthermic intraperitoneal chemotherapy (HIPEC) in the Republic of Korea typically costs from AUD $33,188 to AUD $50,135. Final prices depend on surgical complexity, the primary cancer type, and the hospital location. In Australia, this specialised treatment costs AUD $96,739 on average. Patients can save approximately 57% by choosing Korean medical centres. Quotes generally cover pre-operative imaging, theatre fees, anaesthetic, and initial intensive care monitoring.
Bookimed Expert Insight: Choosing regional hubs like Incheon provides meaningful savings without compromising on clinical quality. Gachon University Gil Medical Center in Incheon was named a Newsweek World’s Best Hospital. It manages 38,000 patients annually and offers significant value compared to Seoul clinics. This centre provides access to 500+ doctors just one hour from the international airport. These regional centres often offer more competitive rates for complex oncology surgeries.
| Republic of Korea | Thailand | Turkey | |
| Hyperthermic Intraperitoneal Chemotherapy (HIPEC) | from AUD $33,188 | from AUD $42,368 | from AUD $9,180 |
No hidden fees – just official clinic prices. Pay at the clinic for Hyperthermic Intraperitoneal Chemotherapy (HIPEC) upon arrival and use a flexible instalment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Hyperthermic Intraperitoneal Chemotherapy (HIPEC) journey.
HIPEC is highly effective for treating advanced abdominal cancers in South Korea. The procedure achieves a 70% success rate in extending survival for peritoneal cancers. Specialists at JCI-accredited centres like Severance Hospital combine heated chemotherapy with cytoreductive surgery. This combination targets residual lesions directly.
Bookimed Expert Insight: Patient volume is a major quality signal in South Korea. Top-tier hospitals like Severance Hospital serve 4,000,000 outpatients annually. This massive case volume means surgical teams handle complex peritoneal carcinomatosis cases with exceptional precision. They also follow refined recovery protocols.
Patient Consensus: Patients value how this treatment provides meaningful survival time even for stage 4 cases. The intensive surgery requires careful candidate selection for the best possible quality of life.
Major South Korean medical centres are global leaders in HIPEC. Examples include Severance Hospital and Gachon University Gil Medical Center. These facilities specialise in managing peritoneal cancers using heated chemotherapy. They use surgical tumour removal alongside JCI-accredited safety standards. Multidisciplinary oncology teams work together to improve patient outcomes.
Bookimed Expert Insight: South Korean oncology centres operate with massive patient volumes. Severance Hospital alone treats over 1.6 million outpatients annually. Surgical teams in this high-volume environment develop exceptional technical proficiency with HIPEC. Specialist teams manage 3,700 beds at these major medical hubs.
Patient Consensus: Patients find South Korea's major cancer centres efficient and professional. The seamless coordination between diverse specialists provides immense confidence during complex abdominal surgeries.
Specialists in South Korea use Hyperthermic Intraperitoneal Chemotherapy to treat advanced cancers that have spread to the peritoneal lining. This intensive treatment targets ovarian, gastric, colorectal, and appendiceal tumours. It is often combined with surgery to remove all visible disease during the same procedure.
Bookimed Expert Insight: South Korea is a hub for high-volume peritoneal oncology. Severance Hospital alone manages 1.6 million outpatients annually. Such massive volume allows oncology teams to specialise deeply. They frequently handle complex cases that smaller international centres might decline.
Patient Consensus: The procedure reaches chemotherapy concentrations up to 1,000 times higher than usual levels. Patients note that surgery can last up to 23 hours. They recommend finding surgeons who perform these highly specialised cases regularly.
HIPEC in South Korea involves intensive heated chemotherapy and major abdominal surgery. Leading Seoul hospitals report a 0% mortality rate and manage complication rates of approximately 20%. Common side effects include nausea, severe fatigue, and intestinal inflammation. Temporary kidney or liver dysfunction may also occur during the 4 to 12-week recovery.
Bookimed Expert Insight: Major Korean centres like Severance Hospital hold JCI accreditation and serve millions of patients. This massive volume means surgical teams are highly specialised in managing complex HIPEC recoveries. Their 0% mortality data shows how well they handle post-op risks. These include sepsis or organ stress.
Patient Consensus: Patients find that Korean medical teams provide structured support for managing common chemotherapy risks. Many prepare for temporary fatigue and bowel issues. While doing so, they focus on the high safety standards in Seoul.
South Korean hospitals perform HIPEC to treat advanced abdominal cancers. They combine cytoreductive surgery with heated chemotherapy. Specialists remove visible tumours first. Then they circulate heated drugs directly through the abdomen for 60 to 120 minutes. This method targets microscopic cancer cells while sparing healthy tissue from systemic side effects.
Bookimed Expert Insight: South Korean oncology centres are unique for combining robotic surgery with HIPEC. Many countries use large open incisions. However, hospitals like Severance Hospital use robotic systems. This helps patients recover faster after removing extensive peritoneal disease. South Korea currently ranks 6th globally for medical requests served on Bookimed.
Patient Consensus: Patients with stage IV stomach cancer report achieving full responses. They are relieved to have access to robotic HIPEC. The concentration of chemotherapy in the abdomen is significantly higher than standard IV treatments.
Recovery after HIPEC in South Korea involves 5–7 days in hospital followed by a 4–12 week period for the return to basic daily activities. Complete physical recovery often takes 3–6 months while the body adjusts to the intensive surgical and heated chemotherapy treatment.
Bookimed Expert Insight: Major Seoul centres like Severance Hospital handle massive patient volumes, allowing specialists to refine post-operative protocols. Data shows that hospitals with JCI accreditation and 2,000+ doctors provide the multidisciplinary support. This support is essential for managing the complex nutritional needs following this A$32,400 to A$49,000 procedure.
Patient Consensus: The first month in South Korea is the most challenging for energy levels. Patients found that eating high-protein foods and taking short daily walks helped them. They felt more like themselves by the third week.